Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: To evaluate the safety and tolerability of REC-4881 Measure: To evaluate the preliminary anti-tumor activity of REC-4881 as measured by Objective Response Rate (ORR). After: Measure: Number of Participants with Dose Limiting Toxicities Measure: Objective Response Rate.
Participant count type changed
Before: Estimated. After: Actual.
Enrollment · participant count changed
Before: 60 participants (planned). After: 18 participants (actual).
Completion date type changed
Before: Estimated. After: Actual.
Primary completion date changed
Before: Jan 2027. After: 24 Feb 2025.
Recruitment status changed
Before: Active not recruiting. After: Terminated.